Literature DB >> 24227981

Periocular sebaceous gland carcinoma: A comprehensive review.

Kaustubh Mulay1, Ekta Aggarwal, Valerie A White.   

Abstract

Sebaceous gland carcinoma (SGC) is a rare tumour occurring at periocular and extra-ocular sites. SGC can be a challenging diagnosis for both clinicians and pathologists. High recurrence rates and a tendency for intra-epithelial spread, locoregional and distant metastases make it important for SGC to be suspected and be included in the differential diagnosis of an eyelid lesion. Early diagnosis, that may sometimes need ancillary testing, and prompt management using a multimodal approach can help reduce morbidity and mortality in patients with SGC.

Entities:  

Keywords:  Carcinoma; Periocular; Sebaceous gland

Year:  2013        PMID: 24227981      PMCID: PMC3770214          DOI: 10.1016/j.sjopt.2013.05.002

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN: 1319-4534


  75 in total

1.  Sebaceous carcinoma of the eyelid: a clinicopathological study.

Authors:  M Zürcher; C R Hintschich; A Garner; C Bunce; J R Collin
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

2.  p53 staining correlates with tumor type and location in sebaceous neoplasms.

Authors:  Sara C Shalin; Aniket Sakharpe; Stephen Lyle; Dina Lev; Eduardo Calonje; Alexander J Lazar
Journal:  Am J Dermatopathol       Date:  2012-04       Impact factor: 1.533

Review 3.  [Incidence of benign and malignant lesions of eyelid and conjunctival tumors].

Authors:  Hiroto Obata; Yuki Aoki; Shunsuke Kubota; Nobuyuki Kanai; Tadahiko Tsuru
Journal:  Nippon Ganka Gakkai Zasshi       Date:  2005-09

4.  Epigenetic inactivation of the E-cadherin gene in eyelid sebaceous gland carcinoma.

Authors:  P Jayaraj; S Sen; A Sharma; K Chosdol; S Kashyap; A Rai; N Pushker; M S Bajaj; S Ghose
Journal:  Br J Dermatol       Date:  2012-07-19       Impact factor: 9.302

5.  p53 represses androgen-induced transactivation of prostate-specific antigen by disrupting hAR amino- to carboxyl-terminal interaction.

Authors:  J L Shenk; C J Fisher; S Y Chen; X F Zhou; K Tillman; L Shemshedini
Journal:  J Biol Chem       Date:  2001-08-14       Impact factor: 5.157

Review 6.  Sebaceous carcinoma of the eyelid associated with retinoblastoma.

Authors:  T Kivelä; S Asko-Seljavaara; U Pihkala; L Hovi; J Heikkonen
Journal:  Ophthalmology       Date:  2001-06       Impact factor: 12.079

7.  Sebaceous carcinoma of the eyelid. Errors in clinical and pathologic diagnosis.

Authors:  J T Wolfe; R P Yeatts; M R Wick; R J Campbell; R R Waller
Journal:  Am J Surg Pathol       Date:  1984-08       Impact factor: 6.394

8.  Accuracy of the clinical diagnosis of chalazion.

Authors:  P C Ozdal; F Codère; S Callejo; A L Caissie; M N Burnier
Journal:  Eye (Lond)       Date:  2004-02       Impact factor: 3.775

9.  Sebaceous cell carcinoma of the ocular adnexa: clinical presentations, histopathology, and outcomes.

Authors:  Alice Song; Keith D Carter; Nasreen A Syed; Julia Song; Jeffrey A Nerad
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2008 May-Jun       Impact factor: 1.746

10.  Eyelid neoplasms in the Beijing Tongren Eye Centre between 1997 and 2006.

Authors:  Xiao Lin Xu; Bin Li; Xian Li Sun; Liao Qing Li; Ruo Jin Ren; Fei Gao; Jost B Jonas
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2008 Sep-Oct
View more
  9 in total

1.  CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid.

Authors:  Tatsuya Yunoki; Tetsushi Hirano; Yoshiaki Tabuchi; Yukihiro Furusawa; Misako Torigoe; Takahiko Nakajima; Johji Imura; Atsushi Hayashi
Journal:  Int Ophthalmol       Date:  2019-09-30       Impact factor: 2.031

2.  Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.

Authors:  Eva Janine Schmitz; Martina C Herwig-Carl; Frank G Holz; Karin U Loeffler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-24       Impact factor: 3.117

3.  A retrospective study of 2228 cases with eyelid tumors.

Authors:  Sha-Sha Yu; Yun Zhao; Hong Zhao; Jin-Yong Lin; Xin Tang
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

4.  High expression of PD-1 and PD-L1 in ocular adnexal sebaceous carcinoma.

Authors:  Thomas J Kandl; Oded Sagiv; Jonathan L Curry; Jing Ning; Junsheng Ma; Courtney W Hudgens; John Van Arnam; Jennifer A Wargo; Bita Esmaeli; Michael T Tetzlaff
Journal:  Oncoimmunology       Date:  2018-07-26       Impact factor: 8.110

5.  Sebaceous Carcinoma: Clinicopathologic Analysis of 29 Cases in a Tertiary Hospital in Korea.

Authors:  Su Kyung Park; Jin Park; Han Uk Kim; Seok Kweon Yun
Journal:  J Korean Med Sci       Date:  2017-08       Impact factor: 2.153

6.  Eyelid sebaceous gland carcinoma: Varied presentations and reconstruction outcome.

Authors:  Syed Ali Raza Rizvi; Md Shahid Alam; Kafil Akhtar
Journal:  Oman J Ophthalmol       Date:  2018 Jan-Apr

7.  Intraoperative Adjunctive Mitomycin C and Cryotherapy for Recurrent Conjunctival Papillary Sebaceous Carcinoma.

Authors:  Natsuki Monai; Reiko Tanabu; Takayuki Gonome; Katsunori Yokoi; Satoshi Urushidate; Satoko Morohashi; Hideaki Hirai; Akira Kurose; Mitsuru Nakazawa
Journal:  Case Rep Ophthalmol       Date:  2018-03-22

8.  Endocrine mucin-producing sweat gland carcinoma of the eyelid: A clinical and histological conundrum.

Authors:  Akshay Gopinathan Nair; Ratika Bhargava; Amjad Umer Furniturewala
Journal:  Indian J Ophthalmol       Date:  2018-07       Impact factor: 1.848

9.  MicroRNA and transcriptome analysis in periocular Sebaceous Gland Carcinoma.

Authors:  John C Bladen; Jun Wang; Ajanthah Sangaralingam; Mariya Moosajee; Caroline Fitchett; Claude Chelala; Michele Beaconsfield; Edel A O'Toole; Michael P Philpott; Daniel G Ezra
Journal:  Sci Rep       Date:  2018-05-14       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.